Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    ict-107
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study of ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo DC

Indicates status has not been verified in more than two years